Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis.

Rui, Tao; Zhang, Xiaobing; Guo, Jufeng; Xiang, Aizhai; Tang, Ning; Liu, Jian; Mao, Zonglei

Rui, Tao; Zhang, Xiaobing; Guo, Jufeng; Xiang, Aizhai; Tang, Ning; Liu, Jian; Mao, Zonglei.

Afiliação

Rui T; Department of Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Zhang X; The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Guo J; Department of Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Xiang A; The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Tang N; Department of Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Liu J; Department of Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Mao Z; Department of Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Cancers (Basel) ; 15(1)2022 Dec 29.

Article em En | MEDLINE | ID: mdl-36612201

Palavras-chave

HCC; biomarker; exosome; miRNA; sRNA-seq

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google